CDKN2A and invasive breast carcinoma: This study aimed to a comprehensive evaluation of the immunoexpression of p16 protein in the nuclear and cytoplasmic locations of the epithelial and stromal compartments of fibroadenoma, invasive breast carcinoma, and a select number of phyllodes tumors.